Hong Kong Stock Exchange · Healthcare
Invest in Guangdong True Health Medical Technology Development stock from India
Indian and foreign residents can buy Guangdong True Health Medical Technology Development (2697) shares directly through Paasa.
By Paasa · Updated
Guangdong True Health Medical Technology Development at a glance
- Price
- HK$262.00-HK$4.40 (1.65%)
- Market cap
- HK$9.34B
- Day range
- HK$260.00 – HK$270.00
- P/E
- —
- Dividend yield
- None
- Volume
- 82.58K
How to invest in Guangdong True Health Medical Technology Development from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 2697 and buy
Find Guangdong True Health Medical Technology Development by name or by its ticker, 2697, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in Guangdong True Health Medical Technology Development from India
What Guangdong True Health Medical Technology Development does
Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product, incl… Guangdong True Health Medical Technology Development operates in the Medical - Devices industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Guangdong True Health Medical Technology Development stock from India?
Yes. Indian residents and NRIs can buy Guangdong True Health Medical Technology Development (2697) shares directly through Paasa. Guangdong True Health Medical Technology Development is listed on the Hong Kong Stock Exchange, in the Medical - Devices industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full Guangdong True Health Medical Technology Development share?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$262.00 a share, size the order by the lot, not by the share.
How are Guangdong True Health Medical Technology Development dividends taxed for Indian investors?
Guangdong True Health Medical Technology Development trades on the Hong Kong Stock Exchange but is domiciled in China, so any withholding on its dividends follows that country's rules rather than those of Hong Kong. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Guangdong True Health Medical Technology Development shares?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.